Press Trust of India | Last Updated: October 05, 2015 15:10 (IST)
Government is focusing on several areas including quality standards and easy visa processes to make India a global destination for healthcare services, Commerce Secretary Rita Teaotia said on Monday.
Press Trust of India | Last Updated: October 04, 2015 15:39 (IST)
Growth momentum of the domestic pharmaceuticals sector is likely to sustain in the near to medium term owing to steady demand witnessed across therapy segments, regular new launches and price hikes taken by companies, a report by rating agency Icra has said.
Thomson Reuters | Last Updated: October 01, 2015 19:21 (IST)
Glencore has told investors it is on track to cut debt and has shown new data about its secretive trading unit in a fresh attempt to dispel market worries over its finances which have knocked 70 per cent off its share price this year.
Press Trust of India | Last Updated: September 29, 2015 21:02 (IST)
The company "has commenced a tender offer through its indirect wholly owned subsidiary, Thea Acquisition Corporation, for all of the outstanding shares of common stock of InSite Vision Incorporated for $0.35 per share in cash, without interest and less any required withholding taxes," Sun Pharma said in a statement.
Press Trust of India | Last Updated: September 27, 2015 10:17 (IST)
The move comes as a setback to SPARC, the research arm of India's largest drugmaker, Sun Pharmaceutical Industries Ltd. The drug, Elepsia XR, was its first to receive an FDA approval.
Thomson Reuters | Last Updated: September 26, 2015 12:58 (IST)
The US Food and Drug Administration (FDA) has revoked an approval issued in March to Sun Pharma Advanced Research Company Ltd (SPARC) to launch a drug for seizures, citing manufacturing quality problems at its production site.
Press Trust of India | Last Updated: September 25, 2015 17:00 (IST)
Fondaparinux is a generic version of the anticoagulant drug Arixtra which is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also indicated for prevention of DVT after major surgery, such as knee and hip replacement worldwide.
Press Trust of India | Last Updated: September 23, 2015 19:06 (IST)
The spokesperson was reacting to a media report that a drug sold by Sun Pharma could be used for executions by the State of Arkansas.
Press Trust of India | Last Updated: September 23, 2015 14:33 (IST)
Drug firm Pfizer on Wednesday said it has entered into a business transfer agreement to sell its Thane plant as a going concern to Vidhi Research and Development LLP for Rs 178 crore.
NDTV | Last Updated: September 23, 2015 13:47 (IST)
Fair trade regulator Competition Commission of India, concerned over a possible nexus between doctors and pharmaceutical companies, has said it will soon carry out a detailed study of pharmaceutical and healthcare services sector in the national capital region (NCR).
Thomson Reuters | Last Updated: September 22, 2015 23:25 (IST)
Serum Institute of India, Asia's largest vaccine maker, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.
Thomson Reuters | Last Updated: September 22, 2015 21:34 (IST)
Serum Institute of India Ltd, Asia's largest vaccine maker, has halted plans to sell a minority stake in the company, as global market volatility has dented the appetite of private equity and sovereign wealth funds for big-ticket investments, its CEO said.
Thomson Reuters | Last Updated: September 22, 2015 21:16 (IST)
Drug maker Glenmark Pharmaceuticals is counting on strong growth in the United States, where it will launch a dozen new medicines, to offset weakness in emerging markets this year, its chief executive said.
Press Trust of India | Last Updated: September 21, 2015 13:21 (IST)
According to a statement issued by BioMarin, the US drugmaker said it will grant Dr Reddy's a non-exclusive licence to its patents on Kuvan (sapropterin dihydrochloride) allowing the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage, which is expected to be more than five years from now.
Press Trust of India | Last Updated: September 20, 2015 16:46 (IST)
Concerned over possible a nexus between doctors and pharmaceutical companies, the Competition Commission of India (CCI) will soon carry out a detailed study of pharmaceutical and healthcare services sector in the national capital region (NCR).
Thomson Reuters | Last Updated: September 19, 2015 14:39 (IST)
Sun Pharma, which last year bought domestic peer Ranbaxy Laboratories Ltd in July, said it may sell low-margin businesses it deemed do not hold long-term value.
Thomson Reuters | Last Updated: September 18, 2015 17:00 (IST)
Intas Pharmaceuticals Ltd could get approval this year to launch a version of Amgen Inc's white blood cell boosting Neulasta drug in the United States, chief financial officer Jayesh Shah said.